Mathys & Squire Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Mathys & Squire Llp

Patent Number:
Title:
Troponin As Marker For Intermittent Atrial Fibrillation
Opposition Date:
May 12, 2021
Patent Number:
Title:
Compositions And Methods For Enhancing And/Or Predicting Dna Amplification
Opposition Date:
Mar 3, 2021
Patent Number:
Title:
Consumable Emulsion
Applicant:
Opposition Date:
Dec 22, 2020
Patent Number:
Title:
Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)
Opposition Date:
Dec 11, 2020
Patent Number:
Title:
Tnt Based Diagnosis Of Paroxysmal Atrial Fibrillation
Opposition Date:
Sep 25, 2020
Patent Number:
Title:
Methods And Compositions For Adoptive Immunotherapy
Opposition Date:
Aug 20, 2020
Patent Number:
Title:
Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6
Opposition Date:
Jul 23, 2020
Patent Number:
Title:
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells
Opposition Date:
Jul 16, 2020
Patent Number:
Title:
Crispr-Based Genome Modification And Regulation
Opposition Date:
Jul 9, 2020
Patent Number:
Title:
Crispr-Based Genome Modification And Regulation
Opposition Date:
Jul 2, 2020

Want to track Mathys & Squire Llp?

Feel free to send us a message here and we will get back to you